Cancer patients with pulmonary embolism have the highest VTE recurrence risk with pancreatic cancer, hematological malignancies, lung cancer, gastric cancer, and brain cancer carrying the greatest thrombotic risk, necessitating extended anticoagulation with LMWH or direct oral anticoagulants preferred over vitamin K antagonists.